PharmacyCodes



Anhydride Arsenieux [French] en es it fr

Anhydride Arsenieux [French] Brand names, Anhydride Arsenieux [French] Analogs

Anhydride Arsenieux [French] Brand Names Mixture

  • No information avaliable

Anhydride Arsenieux [French] Chemical_Formula

As2O3

Anhydride Arsenieux [French] RX_link

http://www.rxlist.com/cgi/generic2/arsenic.htm

Anhydride Arsenieux [French] fda sheet

Anhydride_Arsenieux_[French] FDA

Anhydride Arsenieux [French] msds (material safety sheet)

Anhydride Arsenieux [French] Synthesis Reference

No information avaliable

Anhydride Arsenieux [French] Molecular Weight

197.841 g/mol

Anhydride Arsenieux [French] Melting Point

No information avaliable

Anhydride Arsenieux [French] H2O Solubility

No information avaliable

Anhydride Arsenieux [French] State

Solid

Anhydride Arsenieux [French] LogP

No information avaliable

Anhydride Arsenieux [French] Dosage Forms

Tablet

Anhydride Arsenieux [French] Indication

For induction of remission and consolidation in patients with acute promyelocytic leukemia (APL), and whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression

Anhydride Arsenieux [French] Pharmacology

Arsenic Trioxide is indicated for induction of remission and consolidation in patients with acute promyelocytic leukemia (APL) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy.

Anhydride Arsenieux [French] Absorption

No information avaliable

Anhydride Arsenieux [French] side effects and Toxicity

Symptoms of overdose include convulsions, muscle weakness and confusion.

Anhydride Arsenieux [French] Patient Information

No information avaliable

Anhydride Arsenieux [French] Organisms Affected

Humans and other mammals